Survival trajectory analysis via the Kaplan-Meier method demonstrated a pronounced decline in overall survival rates among CRC cohorts exhibiting attenuated GPD1L expression (P=0.001, Figure 4a). This evidence concerns the gene GPD1L and colorectal carcinoma.